{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:59:30Z","timestamp":1793289570245,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.jpsychires.2020.05.012","type":"journal-article","created":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T05:27:10Z","timestamp":1589347630000},"page":"28-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["The 12-year trend report of antipsychotic usage in a nationwide claims database derived from four million people in Japan"],"prefix":"10.1016","volume":"127","author":[{"given":"Takeo","family":"Hata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsufumi","family":"Kanazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Nishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yoneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Katsumata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2020.05.012_bib1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/acps.12742","article-title":"International trends in clozapine use: a study in 17 countries","volume":"136","author":"Bachmann","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jpsychires.2020.05.012_bib2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/13607863.2017.1401583","article-title":"Off-label use of antipsychotics and associated factors in community living older adults","volume":"23","author":"Bakouni","year":"2019","journal-title":"Aging Ment. Health"},{"key":"10.1016\/j.jpsychires.2020.05.012_bib3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1055\/s-2003-41199","article-title":"Prescribing for inpatients with schizophrenia: an international multi-center comparative study","volume":"36","author":"Bitter","year":"2003","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jpsychires.2020.05.012_bib4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1176\/appi.ps.201300001","article-title":"State and demographic variation in use of depot antipsychotics by Medicaid beneficiaries with schizophrenia","volume":"65","author":"Brown","year":"2014","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.jpsychires.2020.05.012_bib5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/schbul\/sbp116","article-title":"The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements","volume":"36","author":"Buchanan","year":"2010","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jpsychires.2020.05.012_bib6","doi-asserted-by":"crossref","first-page":"972","DOI":"10.4088\/JCP.v67n0615","article-title":"Off-label use of antidepressant, anticonvulsant, and antipsychotic medications among Georgia Medicaid enrollees in 2001","volume":"67","author":"Chen","year":"2006","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.jpsychires.2020.05.012_bib7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.comppsych.2017.09.009","article-title":"Risk factors in early and late onset schizophrenia","volume":"80","author":"Chen","year":"2018","journal-title":"Compr. Psychiatr."},{"key":"10.1016\/j.jpsychires.2020.05.012_bib8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1440-1819.2004.01194.x","article-title":"Antipsychotic drug prescription for schizophrenia in East Asia: rationale for change","volume":"58","author":"Chong","year":"2004","journal-title":"Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2020.05.012_bib9","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/schbul\/sbv023","article-title":"A nation-wide study on the percentage of schizophrenia and bipolar disorder patients who earn minimum wage or above","volume":"42","author":"Davidson","year":"2016","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jpsychires.2020.05.012_bib10","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1176\/appi.ps.201500316","article-title":"Trends in off-label use of second-generation antipsychotics in the Medicare population from 2006 to 2012","volume":"67","author":"Driessen","year":"2016","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.jpsychires.2020.05.012_bib11","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1080\/08039488.2016.1247195","article-title":"Employment outcome and predictors of competitive employment at 2-year follow-up of a vocational rehabilitation programme for individuals with schizophrenia in a high-income welfare society","volume":"71","author":"Evensen","year":"2017","journal-title":"Nord. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2020.05.012_bib12","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/schbul\/sbv141","article-title":"Prevalence, employment rate, and cost of schizophrenia in a high-income welfare society: a population-based study using comprehensive health and welfare registers","volume":"42","author":"Evensen","year":"2016","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jpsychires.2020.05.012_bib13","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1176\/appi.ajp.158.11.1774","article-title":"Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death","volume":"158","author":"Glassman","year":"2001","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2020.05.012_bib14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.psychres.2017.06.069","article-title":"A 20-year multi-followup longitudinal study assessing whether antipsychotic medications contribute to work functioning in schizophrenia","volume":"256","author":"Harrow","year":"2017","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2020.05.012_bib15","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/j.jpsychires.2013.08.024","article-title":"Switching to antipsychotic monotherapy can improve attention and processing speed, and social activity in chronic schizophrenia patients","volume":"47","author":"Hori","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2020.05.012_bib16","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/pcn.12275","article-title":"Psychotropic dose equivalence in Japan","volume":"69","author":"Inada","year":"2015","journal-title":"Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2020.05.012_bib17","doi-asserted-by":"crossref","first-page":"15067","DOI":"10.1038\/nrdp.2015.67","article-title":"Schizophrenia","volume":"1","author":"Kahn","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.jpsychires.2020.05.012_bib18","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S2215-0366(18)30252-9","article-title":"Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study","volume":"5","author":"Kahn","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jpsychires.2020.05.012_bib19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/mp.2011.143","article-title":"Relapse prevention in schizophrenia: a systematic review and meta-analysis of second-generation antipsychotics versus first-generation antipsychotics","volume":"18","author":"Kishimoto","year":"2013","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2020.05.012_bib20","first-page":"642","article-title":"Trends in antipsychotic prescriptions for Japanese outpatients during 2006-2012: a descriptive epidemiological study. Pharmacoepidemiol","volume":"26","author":"Kochi","year":"2017","journal-title":"Drug Saf."},{"key":"10.1016\/j.jpsychires.2020.05.012_bib21","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1176\/appi.ps.201500455","article-title":"Hospital readmission rates among patients with schizophrenia treated with long-acting injectables or oral antipsychotics","volume":"67","author":"MacEwan","year":"2016","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.jpsychires.2020.05.012_bib22","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1177\/0269881109104882","article-title":"Psychiatrists' use, knowledge and attitudes to first- and second-generation antipsychotic long-acting injections: comparisons over 5 years","volume":"24","author":"Patel","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2020.05.012_bib23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archpsyc.64.1.19","article-title":"Lifetime prevalence of psychotic and bipolar I disorders in a general population","volume":"64","author":"Per\u00e4l\u00e4","year":"2007","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.jpsychires.2020.05.012_bib24","doi-asserted-by":"crossref","first-page":"275","DOI":"10.9758\/cpn.2015.13.3.275","article-title":"Antipsychotic prescribing patterns in first-episode schizophrenia: a five-year comparison","volume":"13","author":"Roh","year":"2015","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.jpsychires.2020.05.012_bib25","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.eurpsy.2018.06.004","article-title":"Age of onset and quality of life among males and females with schizophrenia: a national study","volume":"53","author":"Rotstein","year":"2018","journal-title":"Eur. Psychiatr."},{"key":"10.1016\/j.jpsychires.2020.05.012_bib26","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1365-2125.2004.02102.x","article-title":"Antipsychotic polypharmacy in patients with schizophrenia: a multicentre comparative study in East Asia","volume":"58","author":"Sim","year":"2004","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpsychires.2020.05.012_bib27","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1365-2125.2008.03304.x","article-title":"High-dose antipsychotic use in schizophrenia: a comparison between the 2001 and 2004 research on East Asia psychotropic prescription (REAP) studies","volume":"67","author":"Sim","year":"2009","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpsychires.2020.05.012_bib28","first-page":"686","article-title":"Antipsychotics and mortality in a nationwide cohort of 29,823 patients with schizophrenia","volume":"74","author":"Taipale","year":"2017","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2020.05.012_bib29","doi-asserted-by":"crossref","first-page":"286","DOI":"10.9758\/cpn.2016.14.3.286","article-title":"A questionnaire-based study of the views of schizophrenia patients and psychiatric healthcare professionals in Japan about the side effects of clozapine","volume":"14","author":"Takeuchi","year":"2016","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.jpsychires.2020.05.012_bib30","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1176\/appi.ajp.2011.10081224","article-title":"A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia","volume":"168","author":"Tiihonen","year":"2011","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2020.05.012_bib31","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0140-6736(09)60742-X","article-title":"11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)","volume":"374","author":"Tiihonen","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jpsychires.2020.05.012_bib32","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/jamapsychiatry.2017.1322","article-title":"Real-world effectiveness of antipsychotic treatments in a nationwide cohort of 29 823 patients with schizophrenia","volume":"74","author":"Tiihonen","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jpsychires.2020.05.012_bib33","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/bmj.38881.382755.2F","article-title":"Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study","volume":"333","author":"Tiihonen","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.jpsychires.2020.05.012_bib34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.schres.2016.09.014","article-title":"Antipsychotic long-acting injections: a community-based study from 2007 to 2014 of prescribing trends and characteristics associated with initiation","volume":"178","author":"Verdoux","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2020.05.012_bib35","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1192\/bjp.173.4.325","article-title":"Mortality in schizophrenia. Antipsychotic polypharmacy and absence of adjunctive anticholinergics over the course of a 10-year prospective study","volume":"173","author":"Waddington","year":"1998","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jpsychires.2020.05.012_bib36","doi-asserted-by":"crossref","DOI":"10.1111\/appy.12277","article-title":"Comparison of treatment patterns in schizophrenia between China and Japan (2001-2009)","volume":"9","author":"Xiang","year":"2017","journal-title":"Asia Pac. Psychiatr."},{"key":"10.1016\/j.jpsychires.2020.05.012_bib37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1017\/S2045796015000694","article-title":"Trends in the access to and the use of antipsychotic medications and psychotropic co-treatments in Asian patients with schizophrenia","volume":"25","author":"Xiang","year":"2016","journal-title":"Epidemiol. Psychiatr. Sci."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395620302569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395620302569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:15:07Z","timestamp":1758366907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395620302569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":37,"alternative-id":["S0022395620302569"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2020.05.012","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The 12-year trend report of antipsychotic usage in a nationwide claims database derived from four million people in Japan","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2020.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}